• Strategic Aspects of Disclosure and Transparency Beyond Compliance
• UK Disclosure Requirements Updates’
• Patients’ Perspectives around Disclosure
• Considerations on Increased Transparency, Data Privacy and Data Sharing
• Disclosure Requirements in Medical Device Studies
• Non-Interventional studies
• Academia’s Challenges in Clinical Trial Disclosure – Bridging the Gap
• Global Collaboration Initiatives and the Benefits for Transparency & Disclosure
• Lay Summaries are coming!
• Public Demonstration of EU CTIS
• EU Clinical Trial Regulation: Joint Collaboration within Industry Organisation

Professionals from Industry, Academia, Regulatory Authorities and other domain involved in:

• Clinical trial disclosure
• Data transparency/data sharing
• Transparency policies and compliance
• Biometrics
• Medical writing, medical affairs, and medical communications
• Clinical operations
• Compliance/Legal
• Clinical Data Protection responsible
• Regulatory
• Publications
• Data management
• Clinical/Medical Research
• Patient Advocacy

• Benefit from the various perspectives on regulatory, legal aspects and practical challenges from large to smaller sponsor organisations.
• Leverage best practices on the practical implementation through case studies by the exchanging of views between regulators, industry, patients, academia and other stakeholders.
• Gain insights into how the transparency provisions in the EU Clinical Trial Regulation are implemented in the Clinical Trial Information System (CTIS) and how the latter works.
• Gain insights on the impact of Brexit pertaining to the clinical trial registration and results reporting requirements.
• Use a unique opportunity for networking and asking questions to your own specific situation and area of responsibility.